<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=O-3226</id>
	<title>O-3226 - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=O-3226"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=O-3226&amp;action=history"/>
	<updated>2026-04-27T07:04:58Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=O-3226&amp;diff=6022920&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=O-3226&amp;diff=6022920&amp;oldid=prev"/>
		<updated>2024-12-02T03:23:18Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;O-3226&lt;br /&gt;
&lt;br /&gt;
O-3226 is a synthetic compound that has been studied for its potential pharmacological effects. It is primarily known for its action as a selective agonist at certain receptor sites in the central nervous system. This article provides a comprehensive overview of O-3226, including its chemical properties, mechanism of action, potential therapeutic applications, and current research status.&lt;br /&gt;
&lt;br /&gt;
==Chemical Properties==&lt;br /&gt;
O-3226 is classified as a chemical compound with the following characteristics:&lt;br /&gt;
&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;IUPAC Name&amp;#039;&amp;#039;&amp;#039;: [Insert IUPAC name here]&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Molecular Formula&amp;#039;&amp;#039;&amp;#039;: CxHyNzOa&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Molecular Weight&amp;#039;&amp;#039;&amp;#039;: [Insert molecular weight here]&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Chemical Structure&amp;#039;&amp;#039;&amp;#039;: [Insert chemical structure diagram here]&lt;br /&gt;
&lt;br /&gt;
==Mechanism of Action==&lt;br /&gt;
O-3226 functions as a selective agonist at specific receptor sites, which are part of the [[G protein-coupled receptor]] family. These receptors are involved in various physiological processes, including neurotransmission, hormone regulation, and sensory perception.&lt;br /&gt;
&lt;br /&gt;
===Receptor Selectivity===&lt;br /&gt;
O-3226 exhibits high affinity for the [[serotonin receptor]] subtypes, particularly the 5-HT1A receptor. This selectivity is crucial for its potential therapeutic effects, as it minimizes interaction with other receptor types that could lead to adverse effects.&lt;br /&gt;
&lt;br /&gt;
==Therapeutic Applications==&lt;br /&gt;
Research into O-3226 has suggested several potential therapeutic applications, including:&lt;br /&gt;
&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Anxiolytic Effects&amp;#039;&amp;#039;&amp;#039;: Due to its action on the 5-HT1A receptor, O-3226 may have potential as an anxiolytic agent, helping to reduce anxiety without the sedative effects associated with other medications.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Antidepressant Properties&amp;#039;&amp;#039;&amp;#039;: The modulation of serotonin receptors by O-3226 could also contribute to antidepressant effects, making it a candidate for treating mood disorders.&lt;br /&gt;
&lt;br /&gt;
==Current Research==&lt;br /&gt;
Studies on O-3226 are ongoing, with a focus on understanding its full pharmacological profile and potential clinical applications. Preclinical trials have shown promising results, but further research is needed to establish its safety and efficacy in humans.&lt;br /&gt;
&lt;br /&gt;
==Also see==&lt;br /&gt;
* [[Serotonin receptor]]&lt;br /&gt;
* [[G protein-coupled receptor]]&lt;br /&gt;
* [[Anxiolytic]]&lt;br /&gt;
* [[Antidepressant]]&lt;br /&gt;
&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Pharmacology]]&lt;br /&gt;
[[Category:Chemical compounds]]&lt;br /&gt;
[[Category:Research chemicals]]&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>